Soleno Therapeutics (SLNO) Receivables: 2013-2017
Historic Receivables for Soleno Therapeutics (SLNO) over the last 2 years, with Jun 2017 value amounting to $3,000.
- Soleno Therapeutics' Receivables fell 98.96% to $3,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $253,000, marking a year-over-year decrease of 65.11%. This contributed to the annual value of $3,000 for FY2016, which is 98.08% down from last year.
- Latest data reveals that Soleno Therapeutics reported Receivables of $3,000 as of Q2 2017, which was down 97.27% from $110,000 recorded in Q1 2017.
- In the past 5 years, Soleno Therapeutics' Receivables registered a high of $288,000 during Q2 2016, and its lowest value of $3,000 during Q4 2016.
- In the last 3 years, Soleno Therapeutics' Receivables had a median value of $102,000 in 2015 and averaged $99,813.
- Its Receivables has fluctuated over the past 5 years, first spiked by 2,300.00% in 2016, then slumped by 98.96% in 2017.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Receivables stood at $149,605 in 2013, then reached $37,000 in 2014, then surged by 154.05% to $156,127 in 2015, then crashed by 98.08% to $3,000 in 2016, then tumbled by 98.96% to $3,000 in 2017.
- Its last three reported values are $3,000 in Q2 2017, $110,000 for Q1 2017, and $3,000 during Q4 2016.